Pregnant women with anaemia are twice as likely to die during or shortly after pregnancy, compared to those without the condition, according to a study. The study involved over 300,000 women across 29 countries.
Anaemia -- a condition characterised by the lack of healthy red blood cells -- affects 32 million pregnant women worldwide and up to half of all pregnant women in low and middle-income countries.
These women are at an increased risk of anaemia due to higher rates of dietary iron deficiency, inherited blood disorders, nutrient deficiencies and infections such as malaria, HIV, and hookworm.
The study, led by one of an Indian-origin and published in the journal The Lancet Global Health, showed that the odds of maternal death were twice as high in those with severe anaemia compared with those without severe anaemia.
Severe anaemia was defined as antenatal or postnatal haemoglobin concentrations of less than 70 g/L in a blood sample obtained before death.
"If a woman develops severe anaemia at any point in her pregnancy or in the seven days after delivery, she is at a higher risk of dying, making urgent treatment even more important," said Jahnavi Daru, a post-doctoral student at London's Queen Mary University.
"Anaemia is a readily treatable condition but the existing approaches so far have not been able to tackle the problem. Clinicians, policy makers, and healthcare professionals should now focus their attention on preventing anaemia, using a multifaceted approach, not just hoping that iron tablets will solve the problem," Daru said.
Strategies for the prevention and treatment of maternal anaemia include providing oral iron tablets for pregnant women, food fortification with iron, improving access to antenatal care in remote areas, hookworm treatment, and access to transfusion services, the researchers added.
For the study, the team looked at World Health Organization (WHO) data on 3,12,281 pregnancies in 29 countries across Latin America, Africa, Western Pacific, Eastern Mediterranean, and South East Asia.
Of these, 4,189 women had severe anaemia and were matched with 8,218 women without severe anaemia.
--IANS
ng/rt/and/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
